Cytokine-based Preclinical Approaches to the Therapy of Renal Cancar

Antigen-nonspecific approaches to the use of BRMs for cancer treatment have resulted inonly limited success to date. Recent demonstrations of T-Iymphocyte-mediated antigen-specific responses against some human tumors, and the more pronounced effects of these cells in preclinical models have refocusedmuch of responses,